Literature DB >> 30796799

SCAT5 vs. SCAT3 Symptom Reporting Differences and Convergent Validity in Collegiate Athletes.

Breton M Asken1, Zachary M Houck1, Russell M Bauer1, James R Clugston2.   

Abstract

OBJECTIVE: The Sport Concussion Assessment Tool (SCAT), fifth Edition, Symptom Evaluation (S5SE) differs from previous versions by having examinees report trait (i.e. "typical" feelings) as opposed to state (i.e., "how you feel right now") concussion-like symptoms at baseline. This study assessed differences among, and convergent validity of, scores on the S5SE, SCAT3 Symptom Evaluation (S3SE), and the Brief Symptom Inventory (BSI-18).
METHODS: A total of 113 University of Florida varsity athletes completed symptom questionnaires on the same day in a counterbalanced administration. The final sample consisted of 94 participants (mean age ± SD = 18.4 ± 0.8 years, 57% male, 65% white) from 17 sports. We assessed convergent validity using Spearman rank-order correlations. Within-participant differences were analyzed with Wilcoxon Signed-Rank tests. We qualitatively described free-response answers to the S5SE question that asks, "if not feeling 100%, why?".
RESULTS: S5SE total severity score demonstrated adequate convergent validity with both the S3SE (rho = .407, p < .001) and BSI-18 (rho = .432, p < .001). Domain-specific analyses indicated variable convergent validity (rho < 0.4 to rho > 0.6). Severity scores did not differ between the S3SE and S5SE (p = .500), but 24.5% of participants reported S3SE > S5SE and 34.0% S5SE > S3SE. Three themes emerged from qualitative examination of reasons for "not feeling 100%": (1) tiredness/sleep, (2) adjustment difficulties, and (3) academic/athletic stress.
CONCLUSIONS: Adequate convergent validity exists between SCAT5 and SCAT3 symptom severity in collegiate athletes. However, most examinees report different baseline symptom severity when asked to describe their trait (S5SE) versus state symptoms (S3SE). Clinicians should consider using the new SCAT5 Symptom Evaluation as a screening tool for identifying otherwise healthy or "undiagnosed" individuals who would benefit from targeted interventions.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Assessment; Baseline; Brain injury; Concussion; Sport concussion assessment tool

Year:  2020        PMID: 30796799     DOI: 10.1093/arclin/acz007

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  4 in total

1.  Concussion-Recovery Trajectories Among Tactical Athletes: Results From the CARE Consortium.

Authors:  Kathryn L Van Pelt; C Dain Allred; Rachel Brodeur; Kenneth L Cameron; Darren E Campbell; Christopher J D'Lauro; Xuming He; Megan N Houston; Brian R Johnson; Tim F Kelly; Gerald McGinty; Sean K Meehan; Patrick G O'Donnell; Karen Y Peck; Steven J Svoboda; Paul Pasquina; Thomas McAllister; Michael McCrea; Steven P Broglio
Journal:  J Athl Train       Date:  2020-07-01       Impact factor: 2.860

2.  Salivary miRNA Expression in Children With Persistent Post-concussive Symptoms.

Authors:  Katherine E Miller; James P MacDonald; Lindsay Sullivan; Lakshmi Prakruthi Rao Venkata; Junxin Shi; Keith Owen Yeates; Su Chen; Enas Alshaikh; H Gerry Taylor; Amanda Hautmann; Nicole Asa; Daniel M Cohen; Thomas L Pommering; Elaine R Mardis; Jingzhen Yang
Journal:  Front Public Health       Date:  2022-05-30

3.  Research Evaluating Sports ConcUssion Events-Rapid Assessment of Concussion and Evidence for Return (RESCUE-RACER): a two-year longitudinal observational study of concussion in motorsport.

Authors:  Naomi D Deakin; John Suckling; Peter J Hutchinson
Journal:  BMJ Open Sport Exerc Med       Date:  2021-01-13

4.  Effect of a concussion on subsequent baseline SCAT performance in professional rugby players: a retrospective cohort study in global elite Rugby Union.

Authors:  Ross Tucker; Eanna Falvey; Gordon Fuller; James Craig Brown; Martin Raftery
Journal:  BMJ Open       Date:  2020-08-13       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.